7 Stocks That Prove Dividends Matter - 1 of 7

 
 

#1 - Sherwin-Williams (NYSE:SHW)

Sherwin-Williams (SHW)

Years of Consecutive Dividend Growth: 41 Years (Dividend Aristocrat)

Sherwin-Williams (NYSE:SHW) has been giving shareholders solid growth to go along with its super reliable dividend for the last five years. However, the company’s stock has really taken off since its $11 billion purchase of Valspar in 2017.

However, every company is likely to feel some pain from the current mitigation efforts spawned by the coronavirus. Sherwin-Williams reported disappointing fourth-quarter earnings and will likely continue to show weaker numbers in subsequent quarters.

Still, the company has a couple of catalysts that make the company an attractive option as the country works through the coronavirus pandemic. First, interest rates that are at lows not seen since the financial crisis are a motivating factor for current homeowners to make home improvements. And one of the easiest and most cost-effective home improvements that can be made is adding a fresh coat of paint.

Plus, prior to the social distancing guidelines have forced Americans indoors, the housing market was beginning to show the strength that investors were counting on since the Fed first lowered interest rates in 2019.

And to go along with that growth, Sherwin-Williams has a highly reliable dividend that they have increased every year since 1979. And, the company pays out just over 19% of its earnings as dividends.

About Sherwin-Williams

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group. Read More 
Current Price
$306.45
Consensus Rating
Moderate Buy
Ratings Breakdown
13 Buy Ratings, 6 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$337.37 (10.1% Upside)

 

Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>